The effect of the two drugs( Sodium Thiopental or Etomidate) duration and after ECT

Not Applicable

Conditions: Poisoning:Intravenous anaesthetics
Other and unspecified general anaesthetics
Condition 1: Sodium Thiopental. Condition 2: Etomidate.

Registration Number: IRCT2016092826950N2

Lead Sponsor: Vice Chancellor for Research of Isfahan University Of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 64

Inclusion Criteria

Inclusion criteria for the study : All candidates receive Electroconvulsive therapy seizures , of both sexes , age under 18 years , physical status class (ASAI) ; criteria of inclusion: Addiction to alcohol and drugs , age 5 years and older than 18 years , the physical condition of class II patients (A??) above , a history of seizures or epilepsy , brain injury or tumor exclusion criteria : cardio respiratory arrest , requiring intubation and cardiopulmonary resuscitation needs

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood Pressure. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: mmhg with Manometer.;Pulse. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: Beat per minute with Pulse Oximeter.;O2 saturation. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: Percent with Pulse Oximeter.;Recovery Duration. Timepoint: From the end of seizure to full consciousness. Method of measurement: Minute with Timer.;Seizure Duration. Timepoint: From the start to the end of seizure. Method of measurement: Second with Timer.;Back to Breathe Spontaneously. Timepoint: From the end of seizure to respiration. Method of measurement: Second with Timer.

Secondary Outcome Measures

Name	Time	Method
Headache. Timepoint: After recovery. Method of measurement: Ask the patient.;Cough. Timepoint: After recovery. Method of measurement: Ask the patient.;Laryngospasm. Timepoint: After recovery. Method of measurement: Evaluation of patient such as breathing and o2 sat.;Nausea and Vomiting. Timepoint: After recovery. Method of measurement: Ask the patient.;Muscle Pain. Timepoint: After recovery. Method of measurement: Ask the patient.;Pain at injection site. Timepoint: During injection. Method of measurement: Ask the patient.;Myoclonus. Timepoint: From the time of injection until after seizure. Method of measurement: Observation of Complication.